SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-07-181576
Filing Date
2007-08-14
Accepted
2007-08-14 07:33:23
Documents
5
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 210713
2 EXHIBIT 31.1 dex311.htm EX-31.1 8479
3 EXHIBIT 31.2 dex312.htm EX-31.2 8470
4 EXHIBIT 32.1 dex321.htm EX-32.1 3159
5 EXHIBIT 32.2 dex322.htm EX-32.2 3244
  Complete submission text file 0001193125-07-181576.txt   235610
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 071051260
SIC: 2834 Pharmaceutical Preparations